| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA cap binding complex binding | 1.12e-04 | 4 | 87 | 2 | GO:0140262 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SPTBN4 SFMBT1 SRRT NCOR2 DDX17 KAT6A HELZ2 RBM14 SPAG9 TAF15 ZC3H18 ZNF598 RIMS2 SPEN NCOA5 | 1.35e-04 | 1160 | 87 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA binding | 1.86e-04 | 5 | 87 | 2 | GO:0036042 | |
| GeneOntologyCellularComponent | nuclear body | SPTBN4 SART1 SRRT CRNKL1 NCOR2 AMER1 DDX17 KAT6A YLPM1 RBM14 ANKS1B AFDN ZC3H18 CWC22 TRIP12 AKAP8L | 8.57e-07 | 903 | 87 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | SART1 CRNKL1 DDX17 KAT6A YLPM1 RBM14 AFDN ZC3H18 CWC22 TRIP12 AKAP8L | 1.73e-06 | 431 | 87 | 11 | GO:0016607 |
| Domain | COUP_TF | 1.98e-04 | 5 | 84 | 2 | IPR003068 | |
| Domain | Retinoid-X_rcpt/HNF4 | 8.79e-04 | 10 | 84 | 2 | IPR000003 | |
| Domain | Nucleotide-bd_a/b_plait | 1.08e-03 | 258 | 84 | 6 | IPR012677 | |
| Domain | G-alpha | 2.30e-03 | 16 | 84 | 2 | PF00503 | |
| Domain | GproteinA_insert | 2.30e-03 | 16 | 84 | 2 | IPR011025 | |
| Domain | - | 2.30e-03 | 16 | 84 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 2.30e-03 | 16 | 84 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 2.60e-03 | 17 | 84 | 2 | IPR001019 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART1 SRRT PTPN2 CRNKL1 MYOF DDX17 TRIM56 EIF4B HELZ2 RBM14 PACSIN3 BAZ1B KRI1 ZC3H18 GNAS ZNF598 SPEN DNAJA1 CWC22 TRIP12 RPL7A COL1A1 NCOA5 | 3.95e-14 | 1257 | 87 | 23 | 36526897 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART1 SRRT CRNKL1 DDX17 TRIM56 EIF4B YLPM1 HELZ2 RBM14 TAF15 ZC3H18 UPF3B ZNF598 SPEN AKAP8L RPL7A NCOA5 | 1.51e-11 | 807 | 87 | 17 | 22681889 |
| Pubmed | SART1 SRRT CRNKL1 NCOR2 MYOF IGBP1 KANK1 AMER1 DDX17 EIF4B ACOT7 TAF15 UPF3B GNAS PFKM ZNF598 DNAJA1 TRIP12 AKAP8L RPL7A | 2.57e-11 | 1247 | 87 | 20 | 27684187 | |
| Pubmed | SART1 CRNKL1 KIF1A YLPM1 HELZ2 BAZ1B KRI1 AFDN SPAG9 TAF15 ZC3H18 SPEN DNAJA1 TRIP12 RPL7A | 8.19e-11 | 653 | 87 | 15 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART1 SRRT CRNKL1 NCOR2 DDX17 EIF4B YLPM1 RBM14 BAZ1B KRI1 AFDN TAF15 ZC3H18 SPEN CWC22 TRIP12 NDUFS6 | 2.00e-10 | 954 | 87 | 17 | 36373674 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SART1 SRRT NCOR2 DDX17 EIF4B YLPM1 RBM14 BAZ1B KRI1 TAF15 DNAJA1 CWC22 TRIP12 AKAP8L RPL7A DARS2 NCOA5 | 3.47e-10 | 989 | 87 | 17 | 36424410 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFMBT1 SART1 SRRT ABCC1 NCOR2 TMEM201 DDX17 CEP290 YLPM1 RBM14 BAZ1B TAF15 ZC3H18 SPEN DNAJA1 TRIP12 RPL7A NDUFS6 NCOA5 | 3.85e-10 | 1294 | 87 | 19 | 30804502 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SART1 SRRT CRNKL1 DDX17 CEP290 YLPM1 RBM14 PACSIN3 BAZ1B AFDN TAF15 GNAS SPEN DNAJA1 TRIP12 RPL7A NCOA5 | 5.88e-10 | 1024 | 87 | 17 | 24711643 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SART1 SRRT NCOR2 MYOF EIF4B YLPM1 HELZ2 RBM14 BAZ1B AFDN SPAG9 ZC3H18 SPEN TRIP12 AKAP8L | 8.48e-10 | 774 | 87 | 15 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART1 SRRT CRNKL1 TMEM201 DDX17 KIF1A RBM14 BAZ1B KRI1 AFDN UPF3B GNAS PFKM SPEN DNAJA1 CWC22 RPL7A DARS2 NCOA5 | 1.89e-09 | 1425 | 87 | 19 | 30948266 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART1 TGM1 CRNKL1 IGBP1 KANK1 DDX17 EIF4B YLPM1 PACSIN3 DYNC2I1 SPAG9 TAF15 GNAS DNAJA1 CWC22 AKAP8L EXOC4 | 3.58e-09 | 1155 | 87 | 17 | 20360068 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SART1 SRRT DDX17 YLPM1 RBM14 BAZ1B KRI1 TAF15 ZC3H18 SPEN AKAP8L RPL7A NCOA5 | 3.71e-09 | 605 | 87 | 13 | 28977666 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SART1 SRRT DDX17 KAT6A RBM14 BAZ1B KRI1 UPF3B DNAJA1 TRIP12 AKAP8L RPL7A EXOC4 NCOA5 | 6.14e-09 | 759 | 87 | 14 | 35915203 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TGM1 PTPN2 NCOR2 MYOF IGBP1 DDX17 EIF4B YLPM1 RBM14 PACSIN3 ACOT7 AFDN ZC3H18 GNAS PFKM DNAJA1 RPL7A COL1A1 | 6.58e-09 | 1367 | 87 | 18 | 32687490 |
| Pubmed | 7.82e-09 | 103 | 87 | 7 | 32744500 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SART1 SRRT CRNKL1 DDX17 YLPM1 HELZ2 RBM14 TAF15 ZC3H18 SPEN DNAJA1 CWC22 TRIP12 AKAP8L RPL7A NCOA5 | 1.03e-08 | 1082 | 87 | 16 | 38697112 |
| Pubmed | SART1 SRRT CRNKL1 TMEM201 DDX17 EIF4B RBM14 BAZ1B KRI1 ZC3H18 UPF3B GNAS DNAJA1 AKAP8L RPL7A | 1.77e-08 | 971 | 87 | 15 | 33306668 | |
| Pubmed | SRRT CRNKL1 MYOF CELSR1 MGAT1 KIF1A CLK4 TRIM56 EIF4B HELZ2 PACSIN3 BAZ1B AFDN MRPL38 TAF15 ZNF598 SPEN AKAP8L | 2.65e-08 | 1497 | 87 | 18 | 31527615 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART1 SRRT TGM1 CRNKL1 NCOR2 TMEM201 DDX17 RBM14 ACOT7 BAZ1B AFDN PFKM DNAJA1 TRIP12 AKAP8L RPL7A EXOC4 | 3.65e-08 | 1353 | 87 | 17 | 29467282 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.06e-08 | 283 | 87 | 9 | 30585729 | |
| Pubmed | SFMBT1 SART1 IGBP1 AMER1 DDX17 FRMD6 RBM14 AFDN SPAG9 TAF15 SPEN TRIP12 RPL7A | 7.00e-08 | 777 | 87 | 13 | 35844135 | |
| Pubmed | SART1 NCOR2 DDX17 TRIM56 YLPM1 RBM14 TAF15 ZC3H18 GNAS DNAJA1 AKAP8L RPL7A | 8.82e-08 | 655 | 87 | 12 | 35819319 | |
| Pubmed | SART1 SRRT MYOF DDX17 YLPM1 RBM14 PACSIN3 BAZ1B ZC3H18 GNAS CWC22 TRIP12 | 9.58e-08 | 660 | 87 | 12 | 32780723 | |
| Pubmed | 1.26e-07 | 154 | 87 | 7 | 36490346 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.50e-07 | 330 | 87 | 9 | 33301849 | |
| Pubmed | SART1 CRNKL1 DDX17 RBM14 PACSIN3 BAZ1B KRI1 TAF15 ZC3H18 TRIP12 AKAP8L RPL7A NCOA5 | 1.88e-07 | 847 | 87 | 13 | 35850772 | |
| Pubmed | 1.90e-07 | 244 | 87 | 8 | 29884807 | ||
| Pubmed | 1.96e-07 | 245 | 87 | 8 | 35652658 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TMEM201 AMER1 EIF4B CEP290 RBM14 KRI1 DYNC2I1 AFDN PFKM ZNF598 DNAJA1 NDUFS6 EXOC4 | 2.04e-07 | 853 | 87 | 13 | 28718761 |
| Pubmed | SART1 SRRT DDX17 RBM14 KRI1 TAF15 UPF3B PFKM DNAJA1 AKAP8L RPL7A DARS2 | 2.62e-07 | 725 | 87 | 12 | 27025967 | |
| Pubmed | SART1 SRRT CRNKL1 DDX17 RBM14 KRI1 ZC3H18 SPEN CWC22 AKAP8L RPL7A NCOA5 | 2.86e-07 | 731 | 87 | 12 | 29298432 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.19e-07 | 361 | 87 | 9 | 26167880 | |
| Pubmed | 4.42e-07 | 114 | 87 | 6 | 31553912 | ||
| Pubmed | SPTBN4 ILDR2 SRRT TGM1 DDX17 AJM1 EIF4B RBM14 ANKS1B ACOT7 AFDN TAF15 UPF3B PFKM RPL7A EXOC4 | 4.66e-07 | 1431 | 87 | 16 | 37142655 | |
| Pubmed | SPTBN4 SART1 AMER1 NRXN3 DDX17 EIF4B YLPM1 ANKS1B TAF15 PFKM RIMS2 SPEN DNAJA1 TRIP12 AKAP8L RPL7A | 5.16e-07 | 1442 | 87 | 16 | 35575683 | |
| Pubmed | SRRT CRNKL1 DDX17 YLPM1 RBM14 BAZ1B KRI1 TAF15 PFKM ZNF598 RPL7A | 6.03e-07 | 641 | 87 | 11 | 36057605 | |
| Pubmed | SPTBN4 CRNKL1 KIF1A POLG CEP290 YLPM1 ANKS1B DYNC2I1 AFDN MRPL38 DNAJA1 TRIP12 AKAP8L PLXNB3 EXOC4 | 6.53e-07 | 1285 | 87 | 15 | 35914814 | |
| Pubmed | SART1 SRRT TGM1 TMEM201 DDX17 RBM14 BAZ1B TAF15 GNAS RPL7A NCOA5 | 7.13e-07 | 652 | 87 | 11 | 31180492 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRT NCOR2 DDX17 RBM14 ACOT7 AFDN ZC3H18 GNAS SPEN DNAJA1 RPL7A | 8.64e-07 | 665 | 87 | 11 | 30457570 |
| Pubmed | SART1 SRRT CRNKL1 DDX17 EIF4B RBM14 TAF15 ZNF598 AKAP8L RPL7A | 1.23e-06 | 551 | 87 | 10 | 34728620 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.40e-06 | 220 | 87 | 7 | 35785414 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | SPTBN4 SART1 DDX17 TRIM56 EIF4B MXRA8 RBM14 PACSIN3 KRI1 TAF15 D2HGDH NDUFS6 EXOC4 | 1.53e-06 | 1021 | 87 | 13 | 26760575 |
| Pubmed | SART1 SRRT DDX17 KRI1 MRPL38 TAF15 ZC3H18 UPF3B DNAJA1 AKAP8L RPL7A | 1.70e-06 | 713 | 87 | 11 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SART1 SRRT CRNKL1 DDX17 EIF4B RBM14 DNAJA1 CWC22 AKAP8L RPL7A NCOA5 | 1.72e-06 | 714 | 87 | 11 | 28302793 |
| Pubmed | 1.92e-06 | 332 | 87 | 8 | 25693804 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.01e-06 | 582 | 87 | 10 | 20467437 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.20e-06 | 588 | 87 | 10 | 38580884 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.35e-06 | 341 | 87 | 8 | 32971831 | |
| Pubmed | SART1 DDX17 TRIM56 RBM14 BAZ1B ZNF598 DNAJA1 TRIP12 RPL7A EXOC4 | 2.67e-06 | 601 | 87 | 10 | 33658012 | |
| Pubmed | 3.35e-06 | 251 | 87 | 7 | 28077445 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 3.57e-06 | 361 | 87 | 8 | 30344098 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IGBP1 DDX17 EIF4B YLPM1 ACOT7 BAZ1B SPAG9 TAF15 UPF3B PFKM ZNF598 RPL7A | 3.66e-06 | 934 | 87 | 12 | 33916271 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.79e-06 | 364 | 87 | 8 | 24778252 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 4.39e-06 | 169 | 87 | 6 | 23084401 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART1 AMER1 DDX17 TCHP TRIM56 CEP290 RBM14 DYNC2I1 STYXL2 AFDN MRPL38 SPAG9 DARS2 EXOC4 | 4.92e-06 | 1321 | 87 | 14 | 27173435 |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 33503426 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34973414 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 21047794 | ||
| Pubmed | Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. | 6.19e-06 | 2 | 87 | 2 | 12220494 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 8622695 | ||
| Pubmed | Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ. | 6.19e-06 | 2 | 87 | 2 | 30224520 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 25829452 | ||
| Pubmed | SART1 SRRT PTPN2 CRNKL1 NCOR2 YLPM1 RBM14 BAZ1B TAF15 ZC3H18 DNAJA1 NCOA5 | 8.41e-06 | 1014 | 87 | 12 | 32416067 | |
| Pubmed | 9.07e-06 | 111 | 87 | 5 | 12508121 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 9.20e-06 | 411 | 87 | 8 | 35182466 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SFMBT1 SART1 TGM1 NCOR2 ACOT7 MRPL38 SPAG9 ZNF598 SPEN TRIP12 DARS2 | 9.72e-06 | 857 | 87 | 11 | 25609649 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART1 SRRT CRNKL1 DDX17 EIF4B RBM14 PACSIN3 KRI1 ZC3H18 UPF3B PFKM DNAJA1 RPL7A DARS2 | 1.07e-05 | 1415 | 87 | 14 | 28515276 |
| Pubmed | SRRT NCOR2 YLPM1 MSANTD2 BAZ1B KRI1 MRPL38 SPAG9 ZC3H18 HNF4A SPEN DNAJA1 AKAP8L EXOC4 | 1.20e-05 | 1429 | 87 | 14 | 35140242 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.27e-05 | 430 | 87 | 8 | 38172120 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SART1 MYOF EIF4B YLPM1 RBM14 ZNF598 SPEN DNAJA1 TRIP12 EXOC4 | 1.36e-05 | 724 | 87 | 10 | 36232890 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.66e-05 | 321 | 87 | 7 | 32098917 | |
| Pubmed | 1.79e-05 | 451 | 87 | 8 | 36168627 | ||
| Pubmed | A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity. | 1.85e-05 | 3 | 87 | 2 | 30988513 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 34001900 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 21984578 | ||
| Pubmed | Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. | 1.85e-05 | 3 | 87 | 2 | 28297668 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 20520587 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 24268649 | ||
| Pubmed | PTPN2 TMEM201 TCHP BAZ1B KRI1 MRPL38 TAF15 GNAS PFKM DNAJA1 RPL7A DARS2 NDUFS6 EXOC4 | 1.87e-05 | 1487 | 87 | 14 | 33957083 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.95e-05 | 130 | 87 | 5 | 35545047 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR2 MYOF CELSR1 MGAT1 MROH1 BCL2L11 POLG KAT6A HELZ2 SPEN D2HGDH COL1A1 | 1.97e-05 | 1105 | 87 | 12 | 35748872 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PTPN2 POLG DYNC2I1 MRPL38 SPAG9 UPF3B GNAS PFKM ZNF598 DNAJA1 DARS2 NDUFS6 EXOC4 NCOA5 | 1.99e-05 | 1496 | 87 | 14 | 32877691 |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 2.18e-05 | 133 | 87 | 5 | 15604093 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 2.98e-05 | 142 | 87 | 5 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 3.09e-05 | 143 | 87 | 5 | 20198315 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 3.24e-05 | 639 | 87 | 9 | 23443559 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.33e-05 | 358 | 87 | 7 | 32460013 | |
| Pubmed | 3.48e-05 | 645 | 87 | 9 | 25281560 | ||
| Pubmed | 3.49e-05 | 809 | 87 | 10 | 32129710 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.52e-05 | 147 | 87 | 5 | 28977470 | |
| Pubmed | SRRT CRNKL1 TRIM56 YLPM1 HELZ2 RBM14 PACSIN3 KRI1 TAF15 UPF3B GNAS TRIP12 AKAP8L | 3.56e-05 | 1371 | 87 | 13 | 36244648 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.64e-05 | 148 | 87 | 5 | 32538781 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 12544512 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 25919951 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 16129689 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 12205093 | ||
| Pubmed | Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor. | 3.70e-05 | 4 | 87 | 2 | 15062576 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 25244576 | ||
| Pubmed | 3.83e-05 | 653 | 87 | 9 | 33742100 | ||
| Pubmed | 4.12e-05 | 251 | 87 | 6 | 31076518 | ||
| Interaction | CHD4 interactions | SART1 SRRT CRNKL1 DDX17 KAT6A YLPM1 RBM14 BAZ1B KRI1 SPAG9 TAF15 ZC3H18 ZNF598 SPEN DNAJA1 CWC22 TRIP12 AKAP8L RPL7A NCOA5 | 1.48e-09 | 938 | 85 | 20 | int:CHD4 |
| Interaction | SNRNP40 interactions | SART1 SRRT PTPN2 CRNKL1 NCOR2 DDX17 KAT6A RBM14 KRI1 TAF15 ZC3H18 SPEN CWC22 RPL7A NCOA5 | 6.18e-08 | 637 | 85 | 15 | int:SNRNP40 |
| Interaction | SIRT7 interactions | SART1 CRNKL1 KIF1A YLPM1 HELZ2 BAZ1B KRI1 AFDN SPAG9 TAF15 ZC3H18 SPEN DNAJA1 TRIP12 RPL7A | 4.55e-07 | 744 | 85 | 15 | int:SIRT7 |
| Interaction | SMC5 interactions | SART1 SRRT CRNKL1 NCOR2 DDX17 EIF4B YLPM1 RBM14 BAZ1B KRI1 AFDN TAF15 ZC3H18 SPEN CWC22 TRIP12 NDUFS6 | 7.69e-07 | 1000 | 85 | 17 | int:SMC5 |
| Interaction | MEN1 interactions | SART1 SRRT CRNKL1 DDX17 YLPM1 RBM14 PACSIN3 BAZ1B KRI1 AFDN TAF15 ZC3H18 SPEN TRIP12 AKAP8L RPL7A DARS2 | 1.14e-06 | 1029 | 85 | 17 | int:MEN1 |
| Interaction | TOP3B interactions | NCOR2 MYOF CELSR1 MGAT1 MROH1 BCL2L11 POLG TRIM56 KAT6A HELZ2 RBM14 TAF15 GNAS ZNF598 SPEN DNAJA1 D2HGDH AKAP8L EXOC4 COL1A1 | 2.28e-06 | 1470 | 85 | 20 | int:TOP3B |
| Interaction | SNRPC interactions | SART1 SRRT CRNKL1 DDX17 YLPM1 TAF15 ZC3H18 SPEN CWC22 AKAP8L NCOA5 | 2.37e-06 | 440 | 85 | 11 | int:SNRPC |
| Interaction | CHD3 interactions | SART1 SRRT DDX17 KAT6A YLPM1 RBM14 BAZ1B KRI1 TAF15 ZC3H18 HNF4A AKAP8L RPL7A NCOA5 | 3.16e-06 | 757 | 85 | 14 | int:CHD3 |
| Interaction | BMI1 interactions | SRRT TGM1 CRNKL1 YLPM1 HELZ2 RBM14 CBX7 BAZ1B TAF15 HNF4A SPEN AKAP8L NCOA5 | 3.68e-06 | 659 | 85 | 13 | int:BMI1 |
| Interaction | TLE3 interactions | SPTBN4 SRRT NCOR2 IGBP1 DDX17 RBM14 TAF15 SPEN AKAP8L COL1A1 | 4.09e-06 | 376 | 85 | 10 | int:TLE3 |
| Interaction | OBSL1 interactions | SART1 SRRT CRNKL1 DDX17 TRIM56 YLPM1 RBM14 BAZ1B AFDN TAF15 SPEN DNAJA1 TRIP12 RPL7A NCOA5 | 4.94e-06 | 902 | 85 | 15 | int:OBSL1 |
| Interaction | RNF113A interactions | SART1 NCOR2 DDX17 TRIM56 EIF4B YLPM1 RBM14 TAF15 ZC3H18 GNAS DNAJA1 AKAP8L RPL7A | 6.26e-06 | 692 | 85 | 13 | int:RNF113A |
| Interaction | SUPT5H interactions | SART1 CRNKL1 NCOR2 DDX17 CEP290 BAZ1B TAF15 ZC3H18 SPEN NCOA5 | 8.39e-06 | 408 | 85 | 10 | int:SUPT5H |
| Interaction | BIRC3 interactions | SART1 SRRT CRNKL1 NCOR2 TMEM201 DDX17 RBM14 BAZ1B KRI1 AFDN GNAS PFKM SPEN DNAJA1 CWC22 RPL7A DARS2 NCOA5 | 9.12e-06 | 1334 | 85 | 18 | int:BIRC3 |
| Interaction | SPEN interactions | 1.03e-05 | 178 | 85 | 7 | int:SPEN | |
| Interaction | PSPC1 interactions | SART1 SRRT CRNKL1 DDX17 EIF4B YLPM1 RBM14 TAF15 ZC3H18 ZNF598 RPL7A | 1.06e-05 | 515 | 85 | 11 | int:PSPC1 |
| Interaction | CUL7 interactions | SART1 SRRT DDX17 RBM14 BAZ1B AFDN TAF15 ZC3H18 SPEN DNAJA1 D2HGDH RPL7A PLXNB3 NCOA5 | 1.11e-05 | 845 | 85 | 14 | int:CUL7 |
| Interaction | NCOA5 interactions | 1.23e-05 | 121 | 85 | 6 | int:NCOA5 | |
| Interaction | MYCN interactions | SART1 SRRT TGM1 CRNKL1 DDX17 RBM14 BAZ1B MRPL38 TAF15 ZC3H18 UPF3B PFKM DNAJA1 CWC22 AKAP8L RPL7A DARS2 NDUFS6 | 1.35e-05 | 1373 | 85 | 18 | int:MYCN |
| Interaction | HECTD1 interactions | SART1 SRRT DDX17 KIF1A KAT6A RBM14 BAZ1B KRI1 UPF3B DNAJA1 TRIP12 AKAP8L RPL7A EXOC4 NCOA5 | 1.40e-05 | 984 | 85 | 15 | int:HECTD1 |
| Interaction | ZC3H18 interactions | SART1 SRRT CRNKL1 DDX17 CLK4 RBM14 KRI1 TAF15 ZC3H18 SPEN CWC22 AKAP8L RPL7A NCOA5 | 1.68e-05 | 877 | 85 | 14 | int:ZC3H18 |
| Interaction | ARL16 interactions | 2.66e-05 | 83 | 85 | 5 | int:ARL16 | |
| Interaction | SRSF1 interactions | SART1 IGBP1 DDX17 CLK4 RBM14 KRI1 TAF15 ZC3H18 UPF3B TRIP12 RPL7A | 2.70e-05 | 570 | 85 | 11 | int:SRSF1 |
| Interaction | NUPR1 interactions | SART1 SRRT MYOF DDX17 YLPM1 RBM14 PACSIN3 BAZ1B ZC3H18 GNAS CWC22 TRIP12 | 2.85e-05 | 683 | 85 | 12 | int:NUPR1 |
| Interaction | KIF20A interactions | SPTBN4 SART1 DDX17 GNA14 KIF1A CARD19 YLPM1 RBM14 PACSIN3 BAZ1B SPAG9 TAF15 ZC3H18 GNAS AKAP8L | 3.05e-05 | 1052 | 85 | 15 | int:KIF20A |
| Interaction | DCAF4 interactions | 3.06e-05 | 378 | 85 | 9 | int:DCAF4 | |
| Interaction | TOP1 interactions | SART1 SRRT CRNKL1 DDX17 KAT6A YLPM1 RBM14 BAZ1B TAF15 ZC3H18 RPL7A NCOA5 | 3.43e-05 | 696 | 85 | 12 | int:TOP1 |
| Interaction | EIF4A3 interactions | SART1 SRRT CRNKL1 DDX17 EIF4B RBM14 ZC3H18 UPF3B CWC22 RPL7A | 4.70e-05 | 499 | 85 | 10 | int:EIF4A3 |
| Interaction | FUBP1 interactions | 4.82e-05 | 309 | 85 | 8 | int:FUBP1 | |
| Interaction | SRSF6 interactions | 5.02e-05 | 503 | 85 | 10 | int:SRSF6 | |
| Interaction | PRC1 interactions | SPTBN4 SART1 SRRT DDX17 RBM14 BAZ1B TAF15 ZC3H18 GNAS PFKM SPEN CWC22 RPL7A NCOA5 | 5.27e-05 | 973 | 85 | 14 | int:PRC1 |
| Interaction | CDC5L interactions | SART1 CRNKL1 DDX17 YLPM1 TAF15 ZC3H18 GNAS PFKM SPEN DNAJA1 CWC22 RPL7A EXOC4 | 5.75e-05 | 855 | 85 | 13 | int:CDC5L |
| Interaction | SNRPB interactions | SART1 SRRT CRNKL1 DDX17 CEP290 YLPM1 ANKS1B TAF15 ZC3H18 NCOA5 | 6.32e-05 | 517 | 85 | 10 | int:SNRPB |
| Interaction | PHB1 interactions | SART1 SRRT DDX17 RBM14 KRI1 TAF15 ZC3H18 UPF3B PFKM ZNF598 DNAJA1 AKAP8L RPL7A DARS2 NDUFS6 | 6.43e-05 | 1123 | 85 | 15 | int:PHB1 |
| Interaction | RBM25 interactions | 6.58e-05 | 323 | 85 | 8 | int:RBM25 | |
| Interaction | DYNLT1 interactions | 7.16e-05 | 241 | 85 | 7 | int:DYNLT1 | |
| Interaction | CPSF6 interactions | SART1 SRRT CRNKL1 DDX17 YLPM1 RBM14 TAF15 ZC3H18 CWC22 NCOA5 | 7.29e-05 | 526 | 85 | 10 | int:CPSF6 |
| Interaction | SRSF7 interactions | 7.57e-05 | 425 | 85 | 9 | int:SRSF7 | |
| Interaction | SUZ12 interactions | SART1 CRNKL1 CEP290 RBM14 TAF15 ZC3H18 UPF3B HNF4A DNAJA1 TRIP12 AKAP8L | 8.13e-05 | 644 | 85 | 11 | int:SUZ12 |
| Interaction | MECP2 interactions | SART1 SRRT CRNKL1 DDX17 YLPM1 HELZ2 RBM14 TAF15 ZC3H18 SPEN DNAJA1 CWC22 TRIP12 AKAP8L RPL7A NCOA5 | 8.32e-05 | 1287 | 85 | 16 | int:MECP2 |
| Interaction | HSPD1 interactions | PTPN2 DDX17 POLG EIF4B KAT6A PACSIN3 BAZ1B MRPL38 ZC3H18 ZNF598 D2HGDH AKAP8L DARS2 NDUFS6 | 8.91e-05 | 1022 | 85 | 14 | int:HSPD1 |
| Interaction | USP11 interactions | SRRT DDX17 EIF4B RBM14 TAF15 GNAS ZNF598 DNAJA1 TRIP12 NDUFS6 | 8.92e-05 | 539 | 85 | 10 | int:USP11 |
| Interaction | SF3A3 interactions | 9.41e-05 | 340 | 85 | 8 | int:SF3A3 | |
| Interaction | EED interactions | SART1 SRRT CRNKL1 DDX17 CEP290 YLPM1 RBM14 CBX7 BAZ1B AFDN TAF15 HNF4A SPEN CWC22 TRIP12 RPL7A NCOA5 | 9.51e-05 | 1445 | 85 | 17 | int:EED |
| Interaction | HNRNPU interactions | SART1 DMGDH DDX17 EIF4B CEP290 KAT6A RBM14 BAZ1B KRI1 MRPL38 SPAG9 TAF15 ZC3H18 RPL7A | 1.02e-04 | 1035 | 85 | 14 | int:HNRNPU |
| Interaction | FZR1 interactions | SART1 SRRT CRNKL1 TMEM201 DDX17 EIF4B RBM14 BAZ1B KRI1 ZC3H18 UPF3B GNAS DNAJA1 AKAP8L RPL7A | 1.04e-04 | 1172 | 85 | 15 | int:FZR1 |
| Interaction | PRPF40A interactions | 1.09e-04 | 446 | 85 | 9 | int:PRPF40A | |
| Interaction | RBM39 interactions | SART1 SRRT CRNKL1 DDX17 EIF4B YLPM1 RBM14 TAF15 ZC3H18 DNAJA1 CWC22 AKAP8L RPL7A NCOA5 | 1.09e-04 | 1042 | 85 | 14 | int:RBM39 |
| Interaction | ZBTB2 interactions | 1.17e-04 | 450 | 85 | 9 | int:ZBTB2 | |
| Interaction | SMARCC2 interactions | 1.22e-04 | 353 | 85 | 8 | int:SMARCC2 | |
| Interaction | NIN interactions | 1.37e-04 | 359 | 85 | 8 | int:NIN | |
| Interaction | SSRP1 interactions | SART1 SRRT CRNKL1 DDX17 KAT6A YLPM1 RBM14 TAF15 ZC3H18 AKAP8L NCOA5 | 1.40e-04 | 685 | 85 | 11 | int:SSRP1 |
| Interaction | CAMKV interactions | 1.43e-04 | 118 | 85 | 5 | int:CAMKV | |
| Interaction | PAXBP1 interactions | 1.61e-04 | 121 | 85 | 5 | int:PAXBP1 | |
| Interaction | MEIG1 interactions | 1.74e-04 | 5 | 85 | 2 | int:MEIG1 | |
| Interaction | SNRPA interactions | 1.96e-04 | 482 | 85 | 9 | int:SNRPA | |
| Interaction | IFI16 interactions | SART1 CRNKL1 TRIM56 EIF4B HELZ2 RBM14 BAZ1B KRI1 UPF3B TRIP12 RPL7A | 2.01e-04 | 714 | 85 | 11 | int:IFI16 |
| Interaction | ACE2 interactions | SRRT CRNKL1 MYOF DDX17 YLPM1 RBM14 BAZ1B KRI1 TAF15 GNAS PFKM ZNF598 RPL7A NDUFS6 | 2.04e-04 | 1106 | 85 | 14 | int:ACE2 |
| Interaction | SRPK2 interactions | SART1 SRRT AMER1 EIF4B KAT6A KRI1 ZC3H18 UPF3B SPEN TRIP12 RPL7A | 2.08e-04 | 717 | 85 | 11 | int:SRPK2 |
| Interaction | KCTD13 interactions | SPTBN4 ILDR2 SRRT TGM1 DDX17 AJM1 EIF4B RBM14 ANKS1B ACOT7 AFDN TAF15 UPF3B PFKM RPL7A EXOC4 | 2.10e-04 | 1394 | 85 | 16 | int:KCTD13 |
| Interaction | DDX21 interactions | SART1 SRRT CRNKL1 DDX17 YLPM1 BAZ1B KRI1 TAF15 ZC3H18 AKAP8L RPL7A | 2.11e-04 | 718 | 85 | 11 | int:DDX21 |
| Interaction | FBXO32 interactions | 2.24e-04 | 386 | 85 | 8 | int:FBXO32 | |
| Interaction | SNRNP70 interactions | SART1 SRRT CRNKL1 DDX17 KRI1 MRPL38 TAF15 ZC3H18 UPF3B DNAJA1 CWC22 AKAP8L RPL7A | 2.33e-04 | 984 | 85 | 13 | int:SNRNP70 |
| Interaction | MYL10 interactions | 2.44e-04 | 29 | 85 | 3 | int:MYL10 | |
| Interaction | MAP10 interactions | 2.44e-04 | 29 | 85 | 3 | int:MAP10 | |
| Interaction | MBD3 interactions | 2.50e-04 | 295 | 85 | 7 | int:MBD3 | |
| Interaction | HDAC2 interactions | SFMBT1 NCOR2 DDX17 HELZ2 RBM14 CBX7 SPAG9 TAF15 ZC3H18 ZNF598 SPEN DNAJA1 | 2.67e-04 | 865 | 85 | 12 | int:HDAC2 |
| Interaction | PLCH1 interactions | 2.71e-04 | 74 | 85 | 4 | int:PLCH1 | |
| Interaction | SNRPA1 interactions | 2.77e-04 | 300 | 85 | 7 | int:SNRPA1 | |
| Interaction | NUP43 interactions | 2.96e-04 | 625 | 85 | 10 | int:NUP43 | |
| Interaction | SAP18 interactions | 3.06e-04 | 305 | 85 | 7 | int:SAP18 | |
| Interaction | FGL1 interactions | 3.15e-04 | 77 | 85 | 4 | int:FGL1 | |
| Interaction | CIT interactions | SPTBN4 SART1 CRNKL1 DDX17 RBM14 BAZ1B KRI1 TAF15 UPF3B GNAS PFKM DNAJA1 TRIP12 AKAP8L RPL7A NCOA5 | 3.27e-04 | 1450 | 85 | 16 | int:CIT |
| Interaction | CWC22 interactions | 3.27e-04 | 141 | 85 | 5 | int:CWC22 | |
| Interaction | NCBP2 interactions | 3.27e-04 | 141 | 85 | 5 | int:NCBP2 | |
| Interaction | THOC2 interactions | 3.29e-04 | 219 | 85 | 6 | int:THOC2 | |
| Interaction | ECT2 interactions | SPTBN4 SART1 SRRT DDX17 RBM14 PACSIN3 KRI1 SPAG9 GNAS TRIP12 AKAP8L RPL7A | 3.35e-04 | 887 | 85 | 12 | int:ECT2 |
| Interaction | PABPC5 interactions | 3.38e-04 | 142 | 85 | 5 | int:PABPC5 | |
| Interaction | GATA4 interactions | 3.42e-04 | 411 | 85 | 8 | int:GATA4 | |
| Interaction | SRSF3 interactions | 3.52e-04 | 522 | 85 | 9 | int:SRSF3 | |
| Interaction | UBL5 interactions | 3.65e-04 | 80 | 85 | 4 | int:UBL5 | |
| Interaction | ILF3 interactions | SART1 DDX17 TRIM56 KAT6A YLPM1 RBM14 MRPL38 TAF15 ZC3H18 TRIP12 RPL7A NDUFS6 | 3.67e-04 | 896 | 85 | 12 | int:ILF3 |
| Interaction | ARL4D interactions | 3.84e-04 | 146 | 85 | 5 | int:ARL4D | |
| Interaction | ATXN1 interactions | SRRT NCOR2 DDX17 KAT6A RBM14 ACOT7 AFDN ZC3H18 GNAS HNF4A SPEN DNAJA1 RPL7A | 3.94e-04 | 1039 | 85 | 13 | int:ATXN1 |
| Interaction | DSCR9 interactions | 3.96e-04 | 147 | 85 | 5 | int:DSCR9 | |
| Interaction | NLE1 interactions | 4.08e-04 | 228 | 85 | 6 | int:NLE1 | |
| Interaction | RNPS1 interactions | 4.27e-04 | 425 | 85 | 8 | int:RNPS1 | |
| Interaction | PNRC2 interactions | 4.30e-04 | 35 | 85 | 3 | int:PNRC2 | |
| Interaction | CCDC8 interactions | SART1 DDX17 CEP290 RBM14 PACSIN3 BAZ1B AFDN GNAS TRIP12 RPL7A | 4.33e-04 | 656 | 85 | 10 | int:CCDC8 |
| Interaction | DDX17 interactions | 4.34e-04 | 426 | 85 | 8 | int:DDX17 | |
| Interaction | PRP4K interactions | 4.81e-04 | 329 | 85 | 7 | int:PRP4K | |
| Interaction | HDAC11 interactions | 4.90e-04 | 154 | 85 | 5 | int:HDAC11 | |
| Interaction | PRMT1 interactions | SART1 SRRT CRNKL1 DDX17 EIF4B YLPM1 RBM14 TAF15 ZNF598 HNF4A AKAP8L RPL7A | 5.07e-04 | 929 | 85 | 12 | int:PRMT1 |
| Interaction | PCBP1 interactions | SART1 IGBP1 TRIM56 RBM14 ACOT7 TAF15 ZC3H18 UPF3B PFKM RPL7A | 5.17e-04 | 671 | 85 | 10 | int:PCBP1 |
| Interaction | DOT1L interactions | SART1 CRNKL1 DDX17 PACSIN3 BAZ1B KRI1 TAF15 ZC3H18 TRIP12 AKAP8L NCOA5 | 5.67e-04 | 807 | 85 | 11 | int:DOT1L |
| Interaction | SAFB interactions | 5.83e-04 | 244 | 85 | 6 | int:SAFB | |
| Interaction | HNRNPA1 interactions | SRRT CRNKL1 DDX17 EIF4B YLPM1 RBM14 AFDN MRPL38 SPAG9 TAF15 ZC3H18 NCOA5 | 5.90e-04 | 945 | 85 | 12 | int:HNRNPA1 |
| Interaction | CHMP4C interactions | 6.20e-04 | 687 | 85 | 10 | int:CHMP4C | |
| Interaction | TNIP2 interactions | SRRT NCOR2 DDX17 BCL2L11 EIF4B YLPM1 RBM14 SPAG9 ZC3H18 GNAS ZNF598 DNAJA1 | 6.30e-04 | 952 | 85 | 12 | int:TNIP2 |
| Interaction | YAP1 interactions | TGM1 IGBP1 DDX17 GNA14 EIF4B YLPM1 RBM14 BAZ1B AFDN SPAG9 GNAS SPEN RPL7A | 6.47e-04 | 1095 | 85 | 13 | int:YAP1 |
| Cytoband | 2q37.3 | 4.34e-04 | 77 | 87 | 3 | 2q37.3 | |
| Cytoband | 5q35 | 8.75e-04 | 23 | 87 | 2 | 5q35 | |
| Cytoband | 12q24 | 1.04e-03 | 25 | 87 | 2 | 12q24 | |
| Cytoband | 17q21.33 | 2.77e-03 | 41 | 87 | 2 | 17q21.33 | |
| Cytoband | 10p13 | 3.05e-03 | 43 | 87 | 2 | 10p13 | |
| Cytoband | 1p36 | 3.63e-03 | 47 | 87 | 2 | 1p36 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 3.18e-07 | 200 | 86 | 8 | M6583 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SNED1 ILDR2 MYOF CELSR1 KANK1 NRXN3 FRMD6 KIF1A HAP1 SLCO2A1 PACSIN3 MDGA2 SEMA4A DSEL RIMS2 CWC22 COL1A1 | 3.55e-07 | 984 | 86 | 17 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.59e-06 | 232 | 86 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | ILDR2 NRXN3 KIF1A HAP1 CEP290 DYNC2I1 MDGA2 TAF15 RIMS2 DNAJA1 CWC22 | 4.81e-06 | 493 | 86 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | SPTBN4 SNED1 MYOF SLCO2A1 CEP290 YLPM1 PACSIN3 BAZ1B KRI1 DYNC2I1 MDGA2 SEMA4A CWC22 UCMA COL1A1 | 8.12e-06 | 978 | 86 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SPTBN4 CATSPER1 BCL2L11 FRMD6 HAP1 CEP290 KAT6A YLPM1 BAZ1B DYNC2I1 CWC22 AKAP8L RPL7A NDUFS6 UCMA | 9.28e-06 | 989 | 86 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.76e-05 | 279 | 86 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SPTBN4 MYOF CEP290 YLPM1 BAZ1B DYNC2I1 MDGA2 CWC22 UCMA COL1A1 | 2.98e-05 | 492 | 86 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | 3.14e-05 | 495 | 86 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.17e-05 | 395 | 86 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 5.39e-05 | 100 | 86 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ILDR2 KIF1A TRIM56 CEP290 MXRA8 PACSIN3 DYNC2I1 MDGA2 TAF15 RIMS2 DNAJA1 | 6.54e-05 | 654 | 86 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.68e-05 | 248 | 86 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.16e-04 | 271 | 86 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | SNED1 ILDR2 MYOF CELSR1 NRXN3 HAP1 CARD19 SLCO2A1 PACSIN3 MDGA2 SEMA4A CWC22 COL1A1 | 1.41e-04 | 973 | 86 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | ILDR2 NRXN3 BCL2L11 FRMD6 KIF1A HAP1 KAT6A BAZ1B TAF15 RIMS2 CWC22 AKAP8L NDUFS6 | 1.50e-04 | 979 | 86 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.12e-04 | 210 | 86 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SART1 PTPN2 CLK4 CEP290 KAT6A YLPM1 BAZ1B DYNC2I1 MDGA2 AKAP8L | 2.27e-04 | 629 | 86 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.38e-04 | 137 | 86 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ILDR2 NRXN3 KIF1A HAP1 TRIM56 CEP290 MXRA8 MDGA2 UPF3B SEMA4A RIMS2 CWC22 | 2.48e-04 | 893 | 86 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 3.09e-04 | 145 | 86 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SNED1 ILDR2 MYOF NRXN3 KIF1A HAP1 SLCO2A1 PACSIN3 MDGA2 SEMA4A RIMS2 COL1A1 | 5.52e-04 | 976 | 86 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ILDR2 NRXN3 KIF1A HAP1 TRIM56 CEP290 DYNC2I1 MDGA2 TAF15 RIMS2 DNAJA1 CWC22 | 5.88e-04 | 983 | 86 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ILDR2 CELSR1 NRXN3 KIF1A HAP1 CEP290 MDGA2 UPF3B SEMA4A RIMS2 CWC22 COL1A1 | 6.04e-04 | 986 | 86 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ILDR2 CATSPER1 KIF1A HAP1 CEP290 BAZ1B MDGA2 TAF15 UPF3B RIMS2 DNAJA1 CWC22 | 6.20e-04 | 989 | 86 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.52e-04 | 97 | 86 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.77e-04 | 595 | 86 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.46e-06 | 197 | 87 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 181 | 87 | 5 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.97e-05 | 183 | 87 | 5 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-05 | 190 | 87 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.83e-05 | 193 | 87 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.93e-05 | 194 | 87 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.12e-05 | 196 | 87 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 197 | 87 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 198 | 87 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 198 | 87 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 198 | 87 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 198 | 87 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 4.43e-05 | 199 | 87 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 4.43e-05 | 199 | 87 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.54e-05 | 200 | 87 | 5 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.54e-05 | 200 | 87 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 4.54e-05 | 200 | 87 | 5 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 4.54e-05 | 200 | 87 | 5 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.04e-06 | 191 | 86 | 7 | 4303_DN | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.21e-06 | 195 | 86 | 7 | 1539_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 9.52e-06 | 196 | 86 | 7 | 6338_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.05e-05 | 199 | 86 | 7 | 3079_DN | |
| Disease | maturity-onset diabetes of the young type 1 (implicated_via_orthology) | 7.44e-06 | 2 | 81 | 2 | DOID:0111099 (implicated_via_orthology) | |
| Disease | Fanconi syndrome (implicated_via_orthology) | 4.45e-05 | 4 | 81 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | hyperuricemia | 1.02e-04 | 33 | 81 | 3 | EFO_0009104 | |
| Disease | electrodermal activity measurement, skin conductance response amplitude | 1.55e-04 | 7 | 81 | 2 | EFO_0006866, EFO_0006868 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 3.30e-04 | 10 | 81 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 3.30e-04 | 10 | 81 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | mood instability measurement | 4.34e-04 | 128 | 81 | 4 | EFO_0008475 | |
| Disease | hematocrit | 4.43e-04 | 1011 | 81 | 10 | EFO_0004348 | |
| Disease | triacylglycerol 58:12 measurement | 4.83e-04 | 12 | 81 | 2 | EFO_0010439 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 7.64e-04 | 15 | 81 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | cancer (implicated_via_orthology) | 8.69e-04 | 268 | 81 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | protein C measurement | 9.85e-04 | 17 | 81 | 2 | EFO_0004633 | |
| Disease | uric acid measurement | 1.45e-03 | 610 | 81 | 7 | EFO_0004761 | |
| Disease | response to radiation, Hematuria | 1.81e-03 | 23 | 81 | 2 | GO_0009314, HP_0000790 | |
| Disease | body surface area | 1.95e-03 | 643 | 81 | 7 | EFO_0022196 | |
| Disease | body weight | SFMBT1 MGAT1 NRXN3 BCL2L11 ANKS1B MDGA2 GNAS HNF4G CWC22 TRIP12 | 2.34e-03 | 1261 | 81 | 10 | EFO_0004338 |
| Disease | Nephrotic Syndrome | 2.50e-03 | 27 | 81 | 2 | C0027726 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSRQEQEEEGRKRYE | 181 | O00154 | |
| AEEKRRQEEGYYSRL | 1646 | P55196 | |
| RQEEGYYSRLEAERR | 1651 | P55196 | |
| YGEDYHDELQRDGRR | 111 | Q8NEC5 | |
| AFRTREEYEARLERY | 31 | Q9UIG0 | |
| TEDFGRYRERDVLAR | 376 | C9J069 | |
| ELRRIGDEFNAYYAR | 151 | O43521 | |
| REAYTREAYGREAYA | 596 | Q5JTC6 | |
| SEYRERVRENLEVGY | 356 | Q9NYQ6 | |
| ERRRHYNGEAYEDDE | 371 | P31689 | |
| RAVLSERDLYRSGYD | 131 | Q9ULX6 | |
| YERVSRALAELGYER | 146 | Q6P1R3 | |
| QDDRRDVSRYGEDNR | 161 | Q92804 | |
| RYGSDRRLAELSDYR | 601 | Q96PK6 | |
| NYYVGLDLERRDQRG | 186 | Q7Z3H0 | |
| ENRNRNRYRDVSPYD | 41 | P17706 | |
| IYREFERLIGRYDEE | 31 | O60271 | |
| QGDARRRRNENYFDD | 996 | Q7Z6G8 | |
| RSYVEAQEDYLRREA | 1361 | Q9Y618 | |
| YTIARYLQRADERDE | 746 | A4D1F6 | |
| REAYDRDFLARVYGA | 351 | P26572 | |
| DRYEEQERSPRDRDY | 31 | Q9HCG8 | |
| EDRERRYRERKLQYG | 181 | Q8WVS4 | |
| DYINDRQYDSRGRFG | 321 | P41235 | |
| RGARAQAEYRSYVAR | 251 | Q9ULL4 | |
| SGQADDERVREYYLL | 181 | P78318 | |
| DFREREGRLRAAYNL | 91 | P08237 | |
| RREELYRQYFEEIQR | 176 | Q9HCD5 | |
| YDDKDYRRIRFVGRQ | 46 | O75380 | |
| EVRYLVREEDRYRAA | 1136 | P54098 | |
| SRARRSGGELYIDYE | 336 | Q14678 | |
| FAARYNRYREREELQ | 16 | Q8N9T8 | |
| YEGFSRDYRDDVAER | 1001 | Q8NDA8 | |
| EDYINDRQYDSRGRF | 271 | Q14541 | |
| EEERYSERVYTIREG | 41 | Q7Z553 | |
| RRYDQREEREEYSQY | 276 | Q9UQ26 | |
| ESRDEYERQRREEEY | 346 | Q9UQ26 | |
| YERQRREEEYQSRYR | 351 | Q9UQ26 | |
| ARGEVVDYSEQYRIR | 426 | Q92794 | |
| SGRDYREREREYERD | 341 | Q9BZI7 | |
| YVENGRLISDRAARY | 116 | Q96NE9 | |
| YLREQRRELYSRSGE | 456 | Q96A65 | |
| ARSIYERALDVDYRN | 261 | Q9BZJ0 | |
| EQALYYARLEGRNRA | 1246 | O15078 | |
| RYDFRYSEDREQVRG | 521 | P54257 | |
| AYEEKEERDRASGYR | 56 | O95931 | |
| RSGERDCQEFYRALY | 71 | Q96LW7 | |
| EDRERRGDRTIYDYV | 36 | O15033 | |
| LRDLEGSYYLRQERD | 291 | Q9UI17 | |
| SYRDRSETDRAGYAN | 601 | Q92841 | |
| YLEARSLNERDYRDR | 56 | Q9HAZ1 | |
| SLNERDYRDRRYVDE | 61 | Q9HAZ1 | |
| RVYRAPRDRYRDVDE | 1926 | Q9BYK8 | |
| REIGKQTYYRESEER | 31 | A0A1B0GVK7 | |
| QTYYRESEERRLGRS | 36 | A0A1B0GVK7 | |
| GAFDRDAEYIRALRR | 976 | Q8IZU8 | |
| RERITEALSRDGYVY | 386 | Q8N465 | |
| EDQYRREREEATYLL | 646 | Q12756 | |
| VRVRALYDYAGQEAD | 366 | Q9UKS6 | |
| GDKYRDRYDSDRYRD | 221 | P23588 | |
| DRYDSDRYRDGYRDG | 226 | P23588 | |
| DRYDDRGSRDYDRGY | 256 | P23588 | |
| RRDDDYRGGGDRYED | 286 | P23588 | |
| GRVEFRNYCLRYRED | 1291 | P33527 | |
| GIQECYDRRREYQLS | 136 | O95837 | |
| RFQQAGYRDETEYRQ | 26 | Q5JSS6 | |
| LARDRRQATEYEYLD | 36 | Q14242 | |
| DRYFQVARCYRDEGS | 256 | Q6PI48 | |
| AIRTNYNDRYDEIRR | 221 | P62424 | |
| YRNRDEGSYQVDETR | 586 | Q9HDB5 | |
| ESSRGRRVYYDEGVA | 556 | Q5JWF2 | |
| RVRYYAGDERRALSF | 41 | Q9H3S1 | |
| ADVDNRRAGDVYYRE | 106 | Q8TER0 | |
| SRGEYRDYDRNRRER | 51 | Q9BXP5 | |
| DGGRYYRADDANVVR | 1211 | P02452 | |
| RGACAYYDNDALRDR | 591 | Q92959 | |
| YRSFDRYRRRAEQEA | 51 | Q96DV4 | |
| RREERRASYDYNQDR | 616 | Q96T58 | |
| DIREYSYRQRERERE | 691 | Q96T58 | |
| DDSLEEYYGQRSRSR | 471 | Q71H61 | |
| ERYQAEGYRRWGREE | 401 | Q5VZP5 | |
| AAEGYYDIRRVAAQR | 496 | Q9H254 | |
| RYENEYERARREALE | 186 | Q9BT92 | |
| REEGRYDEEVEVYRH | 141 | Q5SNT2 | |
| IDDKYSRREEYRGFT | 681 | O43290 | |
| GQRDRYDRERDREPY | 1681 | P49750 | |
| YEEVDRYSRQGRVAR | 306 | Q86UK7 | |
| LLRYDGYGEDRRADF | 81 | Q9UHJ3 | |
| TDEYEYDELIVRRGQ | 131 | P22735 | |
| YLVVRGYGRVREDDE | 1301 | Q14669 | |
| TGDYLRRRYDGAVQV | 261 | Q93097 | |
| GYRAGWYDEEARERQ | 151 | Q9BRZ2 | |
| EPYHNYRERERERER | 396 | Q86VM9 | |
| RVDELRREYYEEQRN | 81 | Q8WVF2 | |
| LYSAGEQRVYEARDR | 91 | Q9BRK3 | |
| LAARRRRGGYEYSDQ | 361 | Q9BRK3 | |
| SRIRYGGRDYSLDEF | 1696 | Q9NZM1 |